Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Advanced Biomedical Research
ISSN 2277-9175 · Wolters Kluwer Medknow Publications · India
Advanced Biomedical Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.1 (journal website); JCR Q4 (journal website); fully open access; APC about USD 300; median 168 days to acceptance (53 articles, last 24 months); 179 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Advanced Biomedical Research is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Anesthesia and Pain Management, Anesthesia and Sedative Agents and Nausea and vomiting management, together about 20.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Shaghayegh HaghjooyPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Anesthesia and Pain ManagementMedicine8.2%
- Anesthesia and Sedative AgentsMedicine6.9%
- Nausea and vomiting managementMedicine5.6%
- COVID-19 Clinical Research StudiesMedicine5.2%
- Nosocomial Infections in ICUMedicine4.9%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4.5%
- Thyroid Disorders and TreatmentsMedicine4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · MEDICINE, RESEARCH & EXPERIMENTAL · rank 153/191
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.1Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.53LetPub ·
- h-index
- 52OpenAlex ·
- i10-index
- 770OpenAlex ·
- 2-year mean citedness
- 1.2OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 97.48%LetPub ·
Volume
- Articles per year
- 177LetPub ·
Articles by year OpenAlex count · 2,167 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 35 | 3 |
| 2025 | 179 | 179 | 126 |
| 2024 | 112 | 112 | 261 |
| 2023 | 266 | 266 | 970 |
| 2022 | 125 | 125 | 665 |
| 2021 | 54 | 54 | 354 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
168 daysMedian, submission to acceptance · P25–P75 105 days – 291 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 53 articles with submission and acceptance dates (235 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 53 weeksLetPub ·
- Submission to publication (journal-reported)
- about 32 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 300 | Yes | CC BY-NC-SA | |
| OpenAlex | USD 300 | — | — | |
| LetPub | USD 300 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- India
- Language
- English
- ISSN
- 2277-9175
- Latest issue on the website
- Volume 15, Issue 1 (April 2026)
- Official links
FAQ
Frequently asked questions about Advanced Biomedical Research
What CAS zone is Advanced Biomedical Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Advanced Biomedical Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Advanced Biomedical Research?
The journal's website gives an impact factor of 1.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.8, h-index 52.
How long does peer review take at Advanced Biomedical Research?
Based on the dates recorded on 53 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 168 days (interquartile range 105–291 days); authors report an average review time of about 53 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Advanced Biomedical Research in?
The journal's website gives JCR Q4; by category, MEDICINE, RESEARCH & EXPERIMENTAL Q4 (153/191). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Advanced Biomedical Research?
According to LetPub and DOAJ records, Advanced Biomedical Research is indexed in ESCI, Scopus and DOAJ.
Is Advanced Biomedical Research open access, and what is the APC?
Advanced Biomedical Research is a fully open-access journal. APC about USD 300.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .